Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: a phase I study - Wikidata - awgldk - TriplyDB

Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: a phase I study

Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: a phase I study

http://www.wikidata.org/entity/Q33388272

about

Current Understanding on EGFR and Wnt/β-Catenin Signaling in Glioma and Their Possible Crosstalk Novel delivery strategies for glioblastoma A phase I study of LY317615 (enzastaurin) and temozolomide in patients with gliomas (EORTC trial 26054).A phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric brain tumor consortium study.Assessment of perfusion MRI-derived parameters in evaluating and predicting response to antiangiogenic therapy in patients with newly diagnosed glioblastoma.Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma Protein kinase C-beta inhibition induces apoptosis and inhibits cell cycle progression in acquired immunodeficiency syndrome-related non-hodgkin lymphoma cells The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma The Akt signaling pathway: an emerging therapeutic target in malignant melanoma.Using susceptibility-weighted imaging to determine response to combined anti-angiogenic, cytotoxic, and radiation therapy in patients with glioblastoma multiforme.Combining molecular targeted agents with radiation therapy for malignant gliomas Impact of Timing of Concurrent Chemoradiation for Newly Diagnosed Glioblastoma: A Critical Review of Current Evidence AKT/GSK3β Signaling in Glioblastoma.Anti-angiogenic therapy in glioma.Molecular targeted therapy in recurrent glioblastoma: current challenges and future directions.Refined brain tumor diagnostics and stratified therapies: the requirement for a multidisciplinary approach.Role of Akt in human malignant glioma: from oncogenesis to tumor aggressiveness.Targeted therapy in gliomas.Microarray analysis in a cell death resistant glioma cell line to identify signaling pathways and novel genes controlling resistance and malignancy.Identifying Voxels at Risk for Progression in Glioblastoma Based on Dosimetry, Physiologic and Metabolic MRI.

P2860

Q26865911-942D4210-E03D-463C-96DF-34EB5C58E2E4 Q27006099-E469288F-F13E-45D7-8CCC-AD1D17DB8B9F Q33399406-4B71B1FF-B448-496A-B4E0-CAB065745A4F Q33418912-C3977F70-9E48-429A-B2F4-AB120E7462A7 Q34480495-DF096EEE-4452-414C-B413-8D2FE7A0F52D Q35570248-BB1229AD-E303-4059-A9B7-45A5F3E86D8A Q35634280-696FC091-2FA8-496C-9854-7E1AE1C7290E Q35862544-C1E30F88-D9F7-476F-A953-233EE0D1BCBB Q35911227-A97882C2-30AE-4BEA-9398-A6D1E7ACB064 Q36713503-0F2C8E98-2677-49A1-8A01-4DE8DAB91A11 Q37099594-A5066D45-56D8-47C8-BAE0-2E6110CB843E Q37603194-7EE92ADE-ABCD-4AF2-8F3B-AD2168A6F536 Q37710163-CD1C4197-6E06-434B-9569-11AC5332DC34 Q37877409-15743787-64AE-4466-9292-1DC7A4097C42 Q38021521-BB5C0587-5F35-4F4A-A86B-C9D2E5724923 Q38108186-B686B530-F3CE-48E2-9BA9-5ABE40640042 Q38183283-C89A5FB2-0009-4ECB-9414-147558AE7A52 Q38186656-2D77012C-6AC2-443B-83E3-D85802EEC3D9 Q39614127-7B8A1E02-FE6D-4BD5-8A92-B22D20C760C0 Q40116790-20BFC309-27EF-4DC2-9F02-5F02164B35C5

P2860

Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: a phase I study

http://www.wikidata.org/entity/Q33388272

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Enzastaurin plus temozolomide ...... ma multiforme: a phase I study

@ast

Enzastaurin plus temozolomide ...... ma multiforme: a phase I study

@en

type

label

Enzastaurin plus temozolomide ...... ma multiforme: a phase I study

@ast

Enzastaurin plus temozolomide ...... ma multiforme: a phase I study

@en

prefLabel

Enzastaurin plus temozolomide ...... ma multiforme: a phase I study

@ast

Enzastaurin plus temozolomide ...... ma multiforme: a phase I study

@en

P1433

Q33388272-36255CE1-0847-44E2-A240-B9F4B542042B

P1476

Q33388272-44D90948-8337-4C49-943B-2D522B0591C5

P2093

Q33388272-10F7C11B-B66B-4F56-912B-8365A5F945F1

Q33388272-2EF5958A-BB5F-46A8-B6AA-717BF70C6A9F

Q33388272-6A894277-7DB8-428A-983D-06FF33CC8D0F

Q33388272-8E421382-5FE1-440A-8E67-A5E3162E6488

Q33388272-9B363178-6B40-41BA-8127-701CAE086748

Q33388272-A018D449-247D-419F-ABFD-2F57313D7157

Q33388272-B6F2455F-D9CD-4464-8295-F05A16E1E8D1

Q33388272-C8D0A667-0908-4E99-9463-94B8E6275D61

Q33388272-D0187AB7-23AB-48FA-BF62-95D290D3B469

Q33388272-D024D92D-8780-4D7D-9F3C-CC39F5E44D04

P2860

Q33388272-1C2D5BC4-D660-4BEB-A0DA-31F38F4C3BBB

Q33388272-1E648A34-0A2B-4A49-B31B-5B9D0CA1806E

Q33388272-2223BE6F-D46E-4AE2-812D-00A59E5D2082

Q33388272-2470844E-66B7-4E69-9C72-E0450DFEB31C

Q33388272-34CC79B7-51DB-48FD-8377-E5F4F0D41B04

Q33388272-45A617BC-F292-40F8-AD0C-971BCD1EC73A

Q33388272-5F02CC68-C553-4461-9821-30F607610F71

Q33388272-6C955381-6534-4B52-80E0-44ABA6B479FD

Q33388272-6D2EC2D6-4C05-43D2-853F-EDE40294B502

Q33388272-7284CB6B-ADD4-4AA7-B9DF-49DCF3F963B4

P304

Q33388272-6E13AD83-AA13-45D1-A4A7-8C8687D197E7

P31

Q33388272-1124D93F-DDCB-45F7-A766-92F8D6EC6E64

P356

Q33388272-50DDABD5-DE9F-4047-BF4F-7C739705A36C

P433

Q33388272-D70A839D-79E8-46F5-932B-F4FAD41E9258

P478

Q33388272-46A1F12E-2568-45E9-A1EC-6F8DA05BBD2D

P577

Q33388272-870CEA41-E0EF-4D25-B2B8-82327BCB932F

P5875

Q33388272-4A471ADA-28DD-4183-8734-59D0DF27B07B

P698

Q33388272-29CFF6C1-23F6-4DD2-8C38-59EED5427EAF

P921

Q33388272-7188F1DC-547C-45E7-8293-D05B2EBACD98

P932

Q33388272-F878953A-D8AE-4A36-9728-5152839A6A5C

P356

P1433

P1476

Enzastaurin plus temozolomide ...... ma multiforme: a phase I study

@en

P2093

Donald E Thornton

http://www.w3.org/2001/XMLSchema#string

Kathleen R Lamborn

http://www.w3.org/2001/XMLSchema#string

Luna Musib

http://www.w3.org/2001/XMLSchema#string

Maria Hristova-Kazmierski

http://www.w3.org/2001/XMLSchema#string

Mei Yin Polley

http://www.w3.org/2001/XMLSchema#string

Michael D Prados

http://www.w3.org/2001/XMLSchema#string

Nicholas Butowski

http://www.w3.org/2001/XMLSchema#string

R Parvataneni

http://www.w3.org/2001/XMLSchema#string

Steven J Nicol

http://www.w3.org/2001/XMLSchema#string

Susan M Chang

http://www.w3.org/2001/XMLSchema#string

P2860

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

PKC-eta mediates glioblastoma cell proliferation through the Akt and mTOR signaling pathways.

The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas

Phase I pharmacokinetic and pharmacodynamic study of the oral protein kinase C beta-inhibitor enzastaurin in combination with gemcitabine and cisplatin in patients with advanced cancer.

Protein kinase C targeting in antineoplastic treatment strategies.

Chemoradiotherapy in malignant glioma: standard of care and future directions.

New approaches to molecular cancer therapeutics.

LY317615 decreases plasma VEGF levels in human tumor xenograft-bearing mice.

The expression of PAX6, PTEN, vascular endothelial growth factor, and epidermal growth factor receptor in gliomas: relationship to tumor grade and survival.

P304

608-613

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUONC/NOP070

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41435183

http://www.w3.org/2001/XMLSchema#string

P698

20156802

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

2940647

http://www.w3.org/2001/XMLSchema#string